| scholarly article | Q13442814 |
| P50 | author | Sanjay Sinha | Q59543552 |
| Gary K Owens | Q106705276 | ||
| P2093 | author name string | Avril V Somlyo | |
| Hui Xie | |||
| Demetra Perlegas | |||
| P2860 | cites work | Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice | Q24303396 |
| Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor | Q28283897 | ||
| AT2 receptor and vascular smooth muscle cell differentiation in vascular development | Q28508030 | ||
| Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 | ||
| Combinatorial Control of Smooth Muscle–Specific Gene Expression | Q30310837 | ||
| Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta | Q30434958 | ||
| Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Evidence for selective increases in smooth muscle isoactin expression | Q30449270 | ||
| Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells | Q30460026 | ||
| Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells | Q30462210 | ||
| Angiotensin II-induced hypertrophy of rat vascular smooth muscle is associated with increased 18 S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor | Q30464081 | ||
| Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox | Q30471070 | ||
| Substitution of the degenerate smooth muscle (SM) alpha-actin CC(A/T-rich)6GG elements with c-fos serum response elements results in increased basal expression but relaxed SM cell specificity and reduced angiotensin II inducibility | Q30471918 | ||
| Recent progress in angiotensin II type 2 receptor research in the cardiovascular system | Q33534457 | ||
| The AT2 receptor: fact, fancy and fantasy | Q33680652 | ||
| The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer | Q33792965 | ||
| Extinction of autonomous growth potential in embryonic: adult vascular smooth muscle cell heterokaryons | Q34198777 | ||
| Conditional control of gene expression in the mouse | Q34389488 | ||
| Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation | Q34441544 | ||
| Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases | Q34483293 | ||
| A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
| Smooth muscle cell hypertrophy versus hyperplasia in hypertension | Q36384516 | ||
| Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. | Q37357707 | ||
| Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways | Q39451187 | ||
| The potential role of angiotensin II in the vasculature | Q40852199 | ||
| Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells | Q42521529 | ||
| Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats | Q42539666 | ||
| Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells | Q42834005 | ||
| Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor | Q43803591 | ||
| Maternal cardiovascular changes during pregnancy and postpartum in mice | Q43880504 | ||
| Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. | Q44526027 | ||
| Role of angiotensin subtype 2 receptor in neointima formation after vascular injury | Q44979985 | ||
| Non-random X chromosome inactivation in mammalian cells. | Q52185764 | ||
| P433 | issue | 1 | |
| P304 | page(s) | H96-102 | |
| P577 | publication date | 2004-08-26 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development | |
| P478 | volume | 288 |
| Q92132585 | AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin II-infused renal injury mice |
| Q30415577 | AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function |
| Q48241272 | Activation of the renin-angiotensin system within podocytes in diabetes |
| Q37986143 | Angiotensin II type 2 receptor agonists: where should they be applied? |
| Q50713025 | Angiotensin II type 2 receptor regulates the development of pancreatic endocrine cells in mouse embryos. |
| Q42725443 | Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway. |
| Q33785153 | Changes of renal AT1/AT2 receptors and structures in ovine fetuses following exposure to long-term hypoxia |
| Q46915177 | Characterization of agonist-induced vasoconstriction in mouse pulmonary artery. |
| Q38966432 | Conditional expression of the type 2 angiotensin II receptor in mesenchymal stem cells inhibits neointimal formation after arterial injury |
| Q35647604 | The ACE2/Ang-(1-7)/Mas Axis Regulates the Development of Pancreatic Endocrine Cells in Mouse Embryos |
| Q30414541 | The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure |
Search more.